Cellular response to drugs affecting aqueous dynamics.
D000249:Adenosine Monophosphate / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000262:Adenylyl Cyclases / Q000378:metabolism; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D001082:Aqueous Humor / Q000187:drug effects*; D001693:Biological Transport, Active; D002257:Carbonic Anhydrase Inhibitors / Q000494:pharmacology; D002301:Cardiac Glycosides / Q000494:pharmacology; D002462:Cell Membrane / Q000187:drug effects; D002463:Cell Membrane Permeability / Q000187:drug effects; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008968:Molecular Conformation; D009638:Norepinephrine / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D011956:Receptors, Cell Surface; D011955:Receptors, Drug; D013565:Sympatholytics / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D002257:Carbonic Anhydrase Inhibitors; D002301:Cardiac Glycosides; D010726:Phosphodiesterase Inhibitors; D011956:Receptors, Cell Surface; D011955:Receptors, Drug; D013565:Sympatholytics; D013566:Sympathomimetics; D000249:Adenosine Monophosphate; D000255:Adenosine Triphosphate; D000324:Adrenocorticotropic Hormone; D000262:Adenylyl Cyclases; D009638:Norepinephrine; D004837:Epinephrine